Answers are grounded in this paper and cite their sources.
Shows suppression of seizures in Dravet mice, indicating potential for improved treatments.
To develop a novel, mechanistically differentiated, orally available compound with the potential to provide an improved therapeutic profile for the treatment of seizure and non-seizure symptoms of Dravet Syndrome (DS).
No takes yet. Share an insight, caveat, or question.
Cutts et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: